{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:08:33Z","timestamp":1787069313780,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12288-020-01300-0","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:02:15Z","timestamp":1591401735000},"page":"605-615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?"],"prefix":"10.1007","volume":"36","author":[{"given":"Arihant","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charanpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritin","family":"Mohindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepesh","family":"Lad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Khadwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Joseph","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoranjan","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9495-9789","authenticated-orcid":false,"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,6]]},"reference":[{"issue":"4","key":"1300_CR1","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/S1470-2045(20)30149-2","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang H, Zhang L (2020) Risk of COVID-19 for patients with cancer. Lancet Oncol 21(4):e181","journal-title":"Lancet Oncol"},{"issue":"10229","key":"1300_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054\u20131062","journal-title":"Lancet"},{"key":"1300_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/GO.20.00097","volume":"6","author":"A Desai","year":"2020","unstructured":"Desai A, Sachdeva S, Parekh T, Desai R (2020) Covid-19 and cancer: lessons from a pooled meta-analysis. JCO Glob Oncol 6:557\u2013559","journal-title":"JCO Glob Oncol"},{"key":"1300_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.296","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R et al (2020) Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan China. Ann Oncol. https:\/\/doi.org\/10.1016\/j.annonc.2020.03.296 [Epub ahead of print]","journal-title":"Ann Oncol"},{"issue":"6","key":"1300_CR5","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3109\/10428194.2012.740558","volume":"54","author":"BJ Minnema","year":"2013","unstructured":"Minnema BJ, Husain S, Mazzulli T, Hosseini-Mogaddam SM, Patel M, Brandwein J et al (2013) Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort study. Leuk Lymphoma 54(6):1250\u20131255","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"1300_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3324\/haematol.2011.041913","volume":"96","author":"P Ljungman","year":"2011","unstructured":"Ljungman P, de la Camara R, Perez-Bercoff L, Abecasis M, Campuzano JBN, Cannata-Ortiz MJ et al (2011) Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica 96(8):1231\u20131235","journal-title":"Haematologica"},{"key":"1300_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.12688\/f1000research.5251.2","volume":"3","author":"MC Dignani","year":"2015","unstructured":"Dignani MC, Costantini P, Salgueira C, Jord\u00e1n R, Guerrini G, Valledor A et al (2015) Pandemic 2009 influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study. F1000 Res 3:221","journal-title":"F1000 Res"},{"key":"1300_CR8","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.06.20092999","author":"T OpenSAFELY Collaborative","year":"2020","unstructured":"OpenSAFELY Collaborative T, Williamson E, Walker AJ, Bhaskaran K, Bacon S, Bates C et al (2020) OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. MedRxiv. https:\/\/doi.org\/10.1101\/2020.05.06.20092999","journal-title":"MedRxiv"},{"key":"1300_CR9","unstructured":"Physicians (per 1000 people) - India | Data. https:\/\/data.worldbank.org\/indicator\/SH.MED.PHYS.ZS?locations=IN. Accessed on 14 Apr 2020"},{"issue":"1","key":"1300_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/0976-9668.149101","volume":"6","author":"MM Ambroise","year":"2015","unstructured":"Ambroise MM, Ravichandran K, Ramdas A, Sekhar G (2015) A study of blood utilization in a tertiary care hospital in South India. J Nat Sci Biol Med 6(1):106\u2013110","journal-title":"J Nat Sci Biol Med"},{"issue":"1","key":"1300_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12942-020-00202-8","volume":"19","author":"MN Kamel Boulos","year":"2020","unstructured":"Kamel Boulos MN, Geraghty EM (2020) Geographical tracking and mapping of coronavirus disease COVID-19\/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbr. Int J Health Geogr 19(1):8","journal-title":"Int J Health Geogr"},{"key":"1300_CR12","unstructured":"Coronavirus disease COVID-19: EBMT recommendations (Update 23 Mar 2020) | EBMT. https:\/\/www.ebmt.org\/ebmt\/news\/coronavirus-disease-covid-19-ebmt-recommendations-update-march-23-2020"},{"key":"1300_CR13","unstructured":"BSBMTCT recommendations for COVID adult BMT - 27 Mar 2020 - British society of blood and marrow transplantation. https:\/\/bsbmtct.org\/bsbmtct-recommendations-for-covid-adult-bmt-16th-march-2020\/"},{"issue":"2","key":"1300_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/bjh.16620","volume":"189","author":"J Willan","year":"2020","unstructured":"Willan J, King AJ, Hayes S, Collins GP, Peniket A (2020) Care of haematology patients in a COVID-19 epidemic. Br J Haematol 189(2):241\u2013243","journal-title":"Br J Haematol"},{"key":"1300_CR15","unstructured":"Board of Governors (2020) In supersession of the Medical Council of India telemedicine practice guidelines enabling registered medical practitioners to provide healthcare using telemedicine. www.mohfw.gov.in. Accessed on 14 Apr 2020"},{"key":"1300_CR16","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1376","author":"A Back","year":"2020","unstructured":"Back A, Tulsky JA, Arnold RM (2020) Communication skills in the age of COVID-19. Ann Intern Med. https:\/\/doi.org\/10.7326\/M20-1376 [Epub ahead of print]","journal-title":"Ann Intern Med"},{"key":"1300_CR17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2011595","author":"CS Pramesh","year":"2020","unstructured":"Pramesh CS, Badwe RA (2020) Cancer Management in India during Covid-19. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMc2011595","journal-title":"N Engl J Med"},{"key":"1300_CR18","unstructured":"Cancer patient management during the COVID-19 pandemic | ESMO. https:\/\/www.esmo.org\/guidelines\/cancer-patient-management-during-the-covid-19-pandemic. Accessed on 14 Apr 2020"},{"key":"1300_CR19","unstructured":"Guidance document on appropriate management of suspect\/confirmed cases of COVID-19. www.mohfw.gov.in. Accessed on 14 Apr 2020"},{"issue":"2","key":"1300_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4103\/0971-5851.158848","volume":"36","author":"SD Banavali","year":"2015","unstructured":"Banavali SD (2015) Delivery of cancer care in rural India: experiences of establishing a rural comprehensive cancer care facility. Indian J Med Paediatr Oncol 36(2):128","journal-title":"Indian J Med Paediatr Oncol"},{"key":"1300_CR21","unstructured":"Ministry of Health and Family Welfare Directorate General of Health Services [emergency medical relief] novel corornavirus disease (COVID-19) guidelines on use of masks by public. www.moohfw.gov.in. Accessed on 14 Apr 2020"},{"key":"1300_CR22","doi-asserted-by":"crossref","unstructured":"Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance | The Medical Journal of Australia. https:\/\/www.mja.com.au\/journal\/2020\/212\/10\/managing-haematology-and-oncology-patients-during-covid-19-pandemic-interim","DOI":"10.5694\/mja2.50607"},{"key":"1300_CR23","unstructured":"NBTC Interim guidance for blood transfusion services in view of COVID-19. https:\/\/naco.gov.in\/nbtc-interim-guidance-blood-transfusion-services-view-covid-19. Accessed on 14 Apr 2020"},{"issue":"2","key":"1300_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1600-0609.1990.tb00423.x","volume":"45","author":"I Ben-Bassat","year":"2009","unstructured":"Ben-Bassat I, Douer D, Ramot B (2009) Tranexamic acid therapy in acute myeloid leukemia: possible reduction of platelet transfusions. Eur J Haematol 45(2):86\u201389","journal-title":"Eur J Haematol"},{"key":"1300_CR25","unstructured":"Revised National Clinical Mangement guidelines for COVID-19. www.mohfw.gov.in. Accessed on 14 Apr 2020"},{"issue":"10231","key":"1300_CR26","first-page":"1168","volume":"395","author":"T Lancet","year":"2020","unstructured":"Lancet T (2020) Palliative care and the COVID-19 pandemic. The Lancet 395(10231):1168","journal-title":"The Lancet"},{"issue":"4","key":"1300_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF01695861","volume":"67","author":"G Favre","year":"1993","unstructured":"Favre G, Fopp M, Gm\u00fcr J, Tichelli A, Fey MF, Tobler A et al (1993) Factors associated with transfusion requirements during treatment for acute myelogenous leukemia. Ann Hematol 67(4):153\u2013160","journal-title":"Ann Hematol"},{"issue":"9","key":"1300_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1046\/j.1537-2995.1999.39090925.x","volume":"39","author":"I Lopez-Plaza","year":"1999","unstructured":"Lopez-Plaza I, Weissfeld J, Triulzi DJ (1999) The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets. Transfusion 39(9):925\u2013932","journal-title":"Transfusion"},{"key":"1300_CR29","unstructured":"COVID-19 and ALL - Hematology.org. https:\/\/www.hematology.org\/covid-19\/covid-19-and-all. Accessed on 14 Apr 2020"},{"issue":"24","key":"1300_CR30","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1182\/blood-2015-02-627935","volume":"125","author":"Y Chalandon","year":"2015","unstructured":"Chalandon Y, Thomas X, Hayette S, Cayuela JM, Abbal C, Huguet F et al (2015) Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia. Blood 125(24):3711\u20133719","journal-title":"Blood"},{"issue":"5","key":"1300_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1365-2141.2010.08192.x","volume":"149","author":"JL McNeer","year":"2010","unstructured":"McNeer JL, Nachman JB (2010) The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers. Br J Haematol 149(5):638\u2013652","journal-title":"Br J Haematol"},{"issue":"15 suppl","key":"1300_CR32","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1200\/JCO.2018.36.15_suppl.7033","volume":"36","author":"MR Grunwald","year":"2018","unstructured":"Grunwald MR, Boselli D, Bohannon LM, Zimmerman MKA, Ai J, Knight TG et al (2018) Hypomethylating agent (HMA) treatment as a bridge to allogeneic hematopoietic cell transplantation (HCT) for relapsed\/refractory acute myeloid leukemia (RR-AML). J Clin Oncol 36(15 suppl):7033\u20137033","journal-title":"J Clin Oncol"},{"issue":"5","key":"1300_CR33","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s12185-014-1549-3","volume":"99","author":"Y Kim","year":"2014","unstructured":"Kim Y, Kim IH, Kim HJ, Park S, Lee KH, Kim SJ et al (2014) Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes. Int J Hematol 99(5):635\u2013643","journal-title":"Int J Hematol"},{"issue":"1","key":"1300_CR34","doi-asserted-by":"publisher","first-page":"9509","DOI":"10.1038\/s41598-017-10368-0","volume":"7","author":"D Wu","year":"2017","unstructured":"Wu D, Duan C, Chen L, Chen S (2017) Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis. Sci Rep 7(1):9509","journal-title":"Sci Rep"},{"key":"1300_CR35","unstructured":"COVID-19 and acute myeloid leukemia - Hematology.org. https:\/\/www.hematology.org\/covid-19\/covid-19-and-acute-myeloid-leukemia. Accessed on 14 Apr 2020"},{"issue":"23","key":"1300_CR36","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1182\/blood.V126.23.3322.3322","volume":"126","author":"S Varma","year":"2015","unstructured":"Varma S, Yanamandra U, Khadwal A, Prakash G, Suri V, Kumari S et al (2015) High risk apml treated successfully with four cycles of ATO and ATRA combination in resource constrained settings. Blood 126(23):3322\u20133322","journal-title":"Blood"},{"key":"1300_CR37","first-page":"44","volume":"10","author":"W Jastaniah","year":"2018","unstructured":"Jastaniah W, Elimam N, Abdalla K, AlAzmi AA, Aseeri M, Felimban S (2018) High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia. Leuk Res Rep 10:44\u201351","journal-title":"Leuk Res Rep"},{"issue":"11","key":"1300_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1200\/JOP.18.00148","volume":"14","author":"K Dunleavy","year":"2018","unstructured":"Dunleavy K (2018) Approach to the diagnosis and treatment of adult burkitt\u2019s lymphoma. J Oncol Pract 14(11):665\u2013671","journal-title":"J Oncol Pract"},{"key":"1300_CR39","unstructured":"Haematological malignancies: DLBCL, MCL and aggressive T cell lymphoma in the COVID-19 era | ESMO. https:\/\/www.esmo.org\/guidelines\/cancer-patient-management-during-the-covid-19-pandemic\/haematological-malignancies-dlbcl-mcl-and-aggressive-t-cell-lymphoma-in-the-covid-19-era. Accessed on 14 Apr 2020"},{"issue":"1","key":"1300_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1182\/asheducation-2016.1.366","volume":"2016","author":"B Coiffier","year":"2016","unstructured":"Coiffier B, Sarkozy C (2016) Diffuse large B-cell lymphoma: R-CHOP failure\u2013What to do? Hematology 2016(1):366\u2013378","journal-title":"Hematology"},{"issue":"2","key":"1300_CR41","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s12032-013-0520-0","volume":"30","author":"A Avil\u00e9s","year":"2013","unstructured":"Avil\u00e9s A, Jes\u00fas Nambo M, Neri N (2013) Central nervous system prophylaxis in patients with aggressive diffuse large B cell lymphoma: An analysis of 3258 patients in a single center. Med Oncol 30(2):520","journal-title":"Med Oncol"},{"key":"1300_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-019-01213-7","author":"A Jain","year":"2019","unstructured":"Jain A, Jain A, Malhotra P (2019) Re-defining prognosis of hematological malignancies by dynamic response assessment methods: lessons learnt in chronic myeloid leukemia, Hodgkin lymphoma, diffuse large b cell lymphoma and multiple myeloma. Indian J Hematol Blood Transfus. https:\/\/doi.org\/10.1007\/s12288-019-01213-7","journal-title":"Indian J Hematol Blood Transfus"},{"key":"1300_CR43","unstructured":"COVID-19 and indolent lymphomas - Hematology.org. https:\/\/www.hematology.org\/covid-19\/covid-19-and-indolent-lymphomas. Accessed on 14 Apr 2020."},{"key":"1300_CR44","unstructured":"COVID-19 and Hodgkin Lymphoma - Hematology.org. https:\/\/www.hematology.org\/covid-19\/covid-19-and-hodgkin-lymphoma. Accessed on 14 Apr 2020"},{"key":"1300_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1182\/blood.2020006028","volume":"10","author":"J Yahalom","year":"2020","unstructured":"Yahalom J, Dabaja BS, Umberto R et al (2020) ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic. Blood 10:12\u201315. https:\/\/doi.org\/10.1182\/blood.2020006028 [Epub ahead of print]","journal-title":"Blood"},{"key":"1300_CR46","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.2147\/OTT.S189825","volume":"12","author":"S Deng","year":"2019","unstructured":"Deng S, Lin S, Shen J, Zeng Y (2019) Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis. Onco Targets Ther 12:2335\u20132342","journal-title":"Onco Targets Ther"},{"key":"1300_CR47","unstructured":"UK Myeloma Forum guidance to support medical decision-making in the management of myeloma patients during the COVID-19 (coronavirus) outbreak. https:\/\/www.ukmf.org.uk\/guidelines\/covid-19-guidance\/. Accessed on 14 Apr 2020"},{"key":"1300_CR48","unstructured":"COVID-19 and multiple myeloma - Hematology.org. https:\/\/www.hematology.org\/covid-19\/covid-19-and-multiple-myeloma. Accessed on 14 Apr 2020."},{"issue":"27","key":"1300_CR49","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the lugano classification. J Clin Oncol 32(27):3059\u20133068","journal-title":"J Clin Oncol"},{"key":"1300_CR50","unstructured":"COVID-19 and aggressive lymphoma - Hematology.org. https:\/\/www.hematology.org\/covid-19\/covid-19-and-aggressive-lymphoma. Accessed on 14 Apr 2020"},{"issue":"Supplement 1","key":"1300_CR51","first-page":"4133","volume":"130","author":"B Gration","year":"2017","unstructured":"Gration B, Duran A, Mir N, Yuen L, Warner M, Stanley K et al (2017) R-GCVP as second line treatment in elderly patients with DLBCL who fail R-CHOP and are not candidates for intensive therapy. Blood 130(Supplement 1):4133\u20134133","journal-title":"Blood"},{"key":"1300_CR52","unstructured":"Haematological malignancies: Hodgkin lymphoma in the COVID-19 era | ESMO. https:\/\/www.esmo.org\/guidelines\/cancer-patient-management-during-the-covid-19-pandemic\/haematological-malignancies-hodgkin-lymphoma-in-the-covid-19-era. Accessed on 14 Apr 2020"},{"issue":"1","key":"1300_CR53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1200\/JGO.2015.002667","volume":"3","author":"P Ganesan","year":"2017","unstructured":"Ganesan P, Kumar L (2017) Chronic myeloid leukemia in India. J Glob Oncol 3(1):64\u201371","journal-title":"J Glob Oncol"},{"issue":"23","key":"1300_CR54","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1182\/blood.V126.23.3308.3308","volume":"126","author":"A Copeland","year":"2015","unstructured":"Copeland A, Wehbie R, Clayton M, Black A, Rapchak B, Foster MC (2015) The feasibility of a telemedicine platform to monitor adherence and adverse effects of ABL kinase inhibitors. Blood 126(23):3308\u20133308","journal-title":"Blood"},{"key":"1300_CR55","unstructured":"COVID-19 and CML - Hematology.org. https:\/\/www.hematology.org\/covid-19\/covid-19-and-cml. Accessed on 14 Apr 2020"},{"issue":"4","key":"1300_CR56","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","volume":"120","author":"R Hehlmann","year":"2012","unstructured":"Hehlmann R (2012) How I treat CML blast crisis. Blood 120(4):737\u2013747","journal-title":"Blood"},{"key":"1300_CR57","unstructured":"COVID-19 and myeloproliferative neoplasms - Hematology.org. https:\/\/www.hematology.org\/covid-19\/covid-19-and-myeloproliferative-neoplasms. Accessed on 14 Apr 2020"},{"key":"1300_CR58","doi-asserted-by":"publisher","first-page":"m1185","DOI":"10.1136\/bmj.m1185","volume":"368","author":"P Little","year":"2020","unstructured":"Little P (2020) Non-steroidal anti-inflammatory drugs and covid-19. BMJ 368:m1185","journal-title":"BMJ"},{"key":"1300_CR59","first-page":"1023","volume":"14","author":"B Russell","year":"2020","unstructured":"Russell B, Moss C, Rigg A, Van Hemelrijck M (2020) COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? Ecancermedicalscience 14:1023","journal-title":"Ecancermedicalscience"},{"issue":"12","key":"1300_CR60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41408-018-0161-9","volume":"8","author":"T Barbui","year":"2018","unstructured":"Barbui T, De Stefano V, Ghirardi A, Masciulli A, Finazzi G, Vannucchi AM (2018) Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in polycythemia vera. Blood Cancer J 8(12):124","journal-title":"Blood Cancer J"},{"key":"1300_CR61","unstructured":"COVID-19 and aplastic anemia - Hematology.org. https:\/\/www.hematology.org\/covid-19\/covid-19-and-aplastic-anemia. Accessed on 14 Apr 2020."},{"key":"1300_CR62","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/bmt.2012.220","volume":"48","author":"B H\u00f6 Chsmann","year":"2013","unstructured":"H\u00f6 Chsmann B, Moicean A, Risitano A, Ljungman P, Schrezenmeier H (2013) Supportive care in severe and very severe aplastic anemia. Bone Marrow Transpl 48:168\u2013173","journal-title":"Bone Marrow Transpl"},{"key":"1300_CR63","unstructured":"COVID-19 and ITP - Hematology.org. https:\/\/www.hematology.org\/covid-19\/covid-19-and-itp. Accessed on 14 Apr 2020."},{"issue":"1","key":"1300_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12959-020-00220-3","volume":"18","author":"H ten Cate","year":"2020","unstructured":"ten Cate H (2020) Thrombosis management in times of COVID-19 epidemy; a dutch perspective. Thromb J 18(1):7","journal-title":"Thromb J"},{"key":"1300_CR65","unstructured":"ASH RC COVID-19 registry for hematologic malignancy | Ash research collaborative. https:\/\/www.ashresearchcollaborative.org\/covid-19-registry."},{"key":"1300_CR66","unstructured":"COVID-19 Reported data. https:\/\/www.cibmtr.org\/Covid19\/Pages\/default.aspx"},{"key":"1300_CR67","unstructured":"HCC: 1st annual meeting. https:\/\/www.hemecancer.org"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-020-01300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12288-020-01300-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-020-01300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T18:02:27Z","timestamp":1666807347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12288-020-01300-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,6]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1300"],"URL":"https:\/\/doi.org\/10.1007\/s12288-020-01300-0","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,6]]},"assertion":[{"value":"9 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The article does not involve any study with participation of humans or animals by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animals Rights"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}